{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:17:44Z","timestamp":1790835464005,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,16]],"date-time":"2019-08-16T00:00:00Z","timestamp":1565913600000},"content-version":"am","delay-in-days":319,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-17-1-0060"],"award-info":[{"award-number":["W81XWH-17-1-0060"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006710","name":"Wayne State University School of Medicine Research Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.taap.2018.08.001","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T02:06:02Z","timestamp":1533780362000},"page":"151-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation"],"prefix":"10.1016","volume":"356","author":[{"given":"Ognian C.","family":"Ikonomov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Altankov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Sbrissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assia","family":"Shisheva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2018.08.001_bb0005","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2407-14-145","article-title":"AKT inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer","volume":"14","author":"Agrawal","year":"2014","journal-title":"BMC Cancer"},{"issue":"6","key":"10.1016\/j.taap.2018.08.001_bb0010","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1083\/jcb.120.6.1449","article-title":"Depletion of intracellular potassium disrupts coated pits and reversibly inhibits cell polarization during fibroblast spreading","volume":"120","author":"Altankov","year":"1993","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.taap.2018.08.001_bb0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/excr.1995.1038","article-title":"Fibronectin receptor internalization and AP-2 complex reorganization in potassium depleted fibroblasts","volume":"216","author":"Altankov","year":"1995","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.taap.2018.08.001_bb0020","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.chembiol.2013.05.010","article-title":"PIKfyve, a class III PI kinase, is the target of the small molecular IL-12\/IL-23 inhibitor apilimod and a player in Toll-like receptor signaling","volume":"20","author":"Cai","year":"2013","journal-title":"Chem. Biol."},{"issue":"4","key":"10.1016\/j.taap.2018.08.001_bb0025","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2337\/diabetes.49.4.539","article-title":"Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone","volume":"49","author":"Camp","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/j.taap.2018.08.001_bb0030","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/12075","article-title":"Phosphotidylinositol-3-OH kinases are Rab5 effectors","volume":"1","author":"Christoforidis","year":"1999","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.taap.2018.08.001_bb0035","first-page":"C366","article-title":"Active vacuolar H+ ATPase and functional cycle of Rab5 are required for the vacuolation defect triggered by PtdIns(3,5)P2 loss under PIKfyve or Vps34 deficiency","volume":"311","author":"Compton","year":"2016","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.taap.2018.08.001_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1111\/j.1600-0854.2009.00915.x","article-title":"PIKfyve regulation of endosome-linked pathways","volume":"10","author":"De Lartigue","year":"2009","journal-title":"Traffic"},{"issue":"13","key":"10.1016\/j.taap.2018.08.001_bb0045","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1182\/blood-2016-09-736892","article-title":"Identification of apilimod as a first-in-class PIKfyve kinase inhibitor for treatment of B-cell non-Hodgkin lymphoma","volume":"129","author":"Gayle","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.taap.2018.08.001_bb0050","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0074-7696(08)62241-X","article-title":"Cellular adhesiveness and extracellular substrata","volume":"53","author":"Grinnell","year":"1978","journal-title":"Int. Rev. Cytol."},{"key":"10.1016\/j.taap.2018.08.001_bb0055","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1163\/156856295X00337","article-title":"Fibroblast spreading and proliferation on hydrophilic and hydrophobic surfaces is related to tyrosine phosphorylation in focal contacts","volume":"7","author":"Groth","year":"1995","journal-title":"L. Biomater. Sci. Polym. Edn."},{"key":"10.1016\/j.taap.2018.08.001_bb0060","series-title":"Cell surface interaction and tissue compatibility of biomaterials","author":"Groth","year":"1998"},{"key":"10.1016\/j.taap.2018.08.001_bb0065","first-page":"4119","article-title":"Phase 1 clinical safety, pharmacokinetics (PK), and activity of apilimod mesylate (LAM-002A), a first-in-class inhibitor of phosphatidylinositol-3 phosphate 5-kinase (PIKfyve), in patients with relapsed B-cell malignancies","author":"Harb","year":"2017","journal-title":"ASH Ann. Meeting"},{"issue":"7","key":"10.1016\/j.taap.2018.08.001_bb0070","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1158\/1535-7163.MCT-09-1012","article-title":"MK-2206, an allosteric AKT inhibitor, enhances antitumor efficacy by standard chemotherapeutic agents or molecular target drugs in vitro and in vivo","volume":"9","author":"Hirai","year":"2010","journal-title":"Mol. Cancer Ther."},{"issue":"5","key":"10.1016\/j.taap.2018.08.001_bb0075","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1083\/jcb.201412127","article-title":"PI(3,5)P2 controls branched actin dynamics by regulating cortactin-actin interactions","volume":"210","author":"Hong","year":"2015","journal-title":"J. Cell Biol."},{"issue":"28","key":"10.1016\/j.taap.2018.08.001_bb0080","doi-asserted-by":"crossref","first-page":"26141","DOI":"10.1074\/jbc.M101722200","article-title":"Mammalian cell morphology and endocytic membrane homeostasis require enzymatically active phosphoinositide 5-kinase PIKfyve","volume":"276","author":"Ikonomov","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.taap.2018.08.001_bb0085","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1074\/jbc.M108750200","article-title":"Functional dissection of lipid and protein kinase signals of PIKfyve reveals the role of PtdIns 3,5-P2 production for endomembrane integrity","volume":"277","author":"Ikonomov","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.taap.2018.08.001_bb0090","doi-asserted-by":"crossref","first-page":"4742","DOI":"10.1210\/en.2002-220615","article-title":"Requirement for PIKfyve enzymatic activity in acute and long-term insulin cellular effects","volume":"143","author":"Ikonomov","year":"2002","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.taap.2018.08.001_bb0095","first-page":"C393","article-title":"Localized PtdIns 3,5-P2 synthesis to regulate early endosome dynamics and fusion","volume":"291","author":"Ikonomov","year":"2006","journal-title":"Am. J. Phys. Cell Phys."},{"issue":"51","key":"10.1016\/j.taap.2018.08.001_bb0100","doi-asserted-by":"crossref","first-page":"35794","DOI":"10.1074\/jbc.M109.037515","article-title":"PIKfyve-ArPIKfyve-Sac3 core complex. Contact sites and their consequence for Sac3 phosphatase activity and endocytic membrane homeostasis","volume":"284","author":"Ikonomov","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"15","key":"10.1016\/j.taap.2018.08.001_bb0105","doi-asserted-by":"crossref","first-page":"13404","DOI":"10.1074\/jbc.M111.222364","article-title":"The phosphoinositide kinase PIKfyve is vital in early embryonic development:Preimplantation lethality of PIKfyve \u2212\/\u2212 embryos but normality of PIKfyve \u00b1 mice","volume":"286","author":"Ikonomov","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.08.001_bb0110","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1152\/ajpendo.00030.2013","article-title":"Muscle-specific Pikfyve gene disruption causes glucose intolerance, insulin resistance, adiposity, and hyperinsulinemia but not muscle fiber-type switching","volume":"305","author":"Ikonomov","year":"2013","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.taap.2018.08.001_bb0115","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.bbamcr.2015.01.008","article-title":"Class III PI 3-kinase is the main source of PtdIns3P substrate and membrane recruitment signal for PIKfyve constitutive function in podocyte endomembrane homeostasis","volume":"1853","author":"Ikonomov","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.taap.2018.08.001_bb0120","article-title":"Unexpected severe consequences of pikfyve deletion by aP2- or Aq-promoter-driven Cre expression for glucose homeostasis and mammary gland development","volume":"4","author":"Ikonomov","year":"2016","journal-title":"Phys. Rep."},{"issue":"2","key":"10.1016\/j.taap.2018.08.001_bb0125","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/sj.embor.7401155","article-title":"A selective PIKfyve inhibitor blocks PtdIns(3,5)P(2) production and disrupts endomembrane transport and retroviral budding","volume":"9","author":"Jefferies","year":"2008","journal-title":"EMBO Rep."},{"issue":"7","key":"10.1016\/j.taap.2018.08.001_bb0130","doi-asserted-by":"crossref","first-page":"849","DOI":"10.4161\/auto.6845","article-title":"Does bafilomycin A1 block the fusion of autophagosomes with lysosomes?","volume":"4","author":"Klionsky","year":"2008","journal-title":"Autophagy"},{"key":"10.1016\/j.taap.2018.08.001_bb0135","series-title":"Mammalian Cell viability: Methods and Protocols (Martin J. Stoddart Editor)","first-page":"7","article-title":"Cell viability analysis using Trypan Blue: manual and automated methods","author":"Louis","year":"2011"},{"key":"10.1016\/j.taap.2018.08.001_bb0140","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: Navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.taap.2018.08.001_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2011.12.004","article-title":"Cation trapping by cellular acidic compartments: beyond the concept of lysosomotropic drugs","volume":"259","author":"Marceau","year":"2012","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"3","key":"10.1016\/j.taap.2018.08.001_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060152","article-title":"Inhibition of PIKfyve by YM-201636 dysregulates autophagy and leads to apoptosis-independent neuronal cell death","volume":"8","author":"Martin","year":"2013","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.taap.2018.08.001_bb0155","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tibs.2005.11.013","article-title":"Phosphatidylinositol 3,5-bisphosphate: metabolism and cellular functions","volume":"31","author":"Michell","year":"2006","journal-title":"Trends Biochem. Sci."},{"issue":"1","key":"10.1016\/j.taap.2018.08.001_bb0160","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/embor.2012.183","article-title":"Production of phosphatidylinositol 5-phosphate via PIKfyve and MTMR3 regulates cell migration","volume":"14","author":"Oppelt","year":"2013","journal-title":"EMBO Rep."},{"issue":"9","key":"10.1016\/j.taap.2018.08.001_bb0165","doi-asserted-by":"crossref","first-page":"3989","DOI":"10.1091\/mbc.e06-03-0239","article-title":"Fab1 phosphatidylinositol 3-phosphate 5-kinase controls trafficking but not silencing of endocytosed receptors","volume":"17","author":"Rusten","year":"2006","journal-title":"Mol. Biol. Cell"},{"issue":"1\u20132","key":"10.1016\/j.taap.2018.08.001_bb0170","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0303-7207(01)00539-1","article-title":"Selective insulin-induced activation of class I(A) phosphoinositide 3-kinase in PIKfyve immune complexes from 3T3-L1 adipocytes","volume":"181","author":"Sbrissa","year":"2001","journal-title":"Mol. Cell. Endocrinol."},{"issue":"8","key":"10.1016\/j.taap.2018.08.001_bb0175","doi-asserted-by":"crossref","first-page":"6073","DOI":"10.1074\/jbc.M110194200","article-title":"Phosphatidylinositol 3-phosphate-interacting domains in PIKfyve. Binding specificity and role in PIKfyve. Endomenbrane localization","volume":"277","author":"Sbrissa","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"11","key":"10.1016\/j.taap.2018.08.001_bb0180","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1210\/en.2004-0489","article-title":"Role for a novel signaling intermediate, phosphatidylinositol 5-phosphate, in insulin-regulated F-actin stress fiber breakdown and GLUT4 translocation","volume":"145","author":"Sbrissa","year":"2004","journal-title":"Endocrinology"},{"issue":"33","key":"10.1016\/j.taap.2018.08.001_bb0185","doi-asserted-by":"crossref","first-page":"23878","DOI":"10.1074\/jbc.M611678200","article-title":"Core protein machinery for mammalian phosphatidylinositol 3,5-bisphosphate synthesis and turnover that regulates the progression of endosomal transport. Novel Sac phosphatase joins the ArPIKfyve-PIKfyve complex","volume":"282","author":"Sbrissa","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2018.08.001_bb0190","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jmb.2008.10.009","article-title":"ArPIKfyve homomeric and heteromeric interactions scaffold PIKfyve and Sac3 in a complex to promote PIKfyve activity and functionality","volume":"384","author":"Sbrissa","year":"2008","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.taap.2018.08.001_bb0195","first-page":"C436","article-title":"Functional dissociation between PIKfyve-synthesized PtdIns5P and PtdIns(3,5)P2 by means of PIKfyve inhibitor YM201636","volume":"303","author":"Sbrissa","year":"2012","journal-title":"Am. J. Phys. Cell Phys."},{"key":"10.1016\/j.taap.2018.08.001_bb0200","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1073\/pnas.79.6.1889","article-title":"3-methyladenine: specific inhibitor of autophagic\/lysosomal protein degradation in isolated rat hepatocytes","volume":"79","author":"Seglen","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.taap.2018.08.001_bb0205","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-1033.1979.tb12956.x","article-title":"Inhibition of the lysosomal pathway of protein degradation in isolated rat hepatocytes by ammonia, methylamine, chloroquine and leupeptin","volume":"95","author":"Seglen","year":"1979","journal-title":"Eur. J. Biochem."},{"issue":"6","key":"10.1016\/j.taap.2018.08.001_bb0210","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cellbi.2008.01.006","article-title":"PIKfyve: Partners, significance, debates and paradoxes","volume":"32","author":"Shisheva","year":"2008","journal-title":"Cell Biol. Int."},{"key":"10.1016\/j.taap.2018.08.001_bb0215","first-page":"127","article-title":"PIKfyve and its lipid products in health and in sickness","volume":"362","author":"Shisheva","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.taap.2018.08.001_bb0220","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.abb.2013.07.023","article-title":"PtdIns5P: news and views of its appearance, disappearance and deeds","volume":"538","author":"Shisheva","year":"2013","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.taap.2018.08.001_bb0225","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/bies.201400129","article-title":"Plentiful PtdIns5P from scanty PtdIns(3,5)P2 or from ample PtdIns? PIKfyve-dependent models: evidence and speculation","volume":"37","author":"Shisheva","year":"2015","journal-title":"Bioassays"},{"issue":"6","key":"10.1016\/j.taap.2018.08.001_bb0230","doi-asserted-by":"crossref","first-page":"770","DOI":"10.15252\/emmm.201607096","article-title":"Inhibition of PIKfyve prevents myocardial apoptosis and hypertrophy through activation of SIRT3 in obese mice","volume":"9","author":"Tronchere","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.taap.2018.08.001_bb0235","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1681\/ASN.2015050555","article-title":"Distinct requirements for vacuolar protein sorting 34 downstream effector phosphatidylinositol 3-phosphate 5-kinase in podocytes versus proximal tubular cells","volume":"27","author":"Venkatareddy","year":"2016","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.taap.2018.08.001_bb0240","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.molcel.2014.12.007","article-title":"PI(5)P regulates autophagosome biogenesis","volume":"57","author":"Vicinanza","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.taap.2018.08.001_bb0245","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1247\/csf.23.33","article-title":"Bafilomycin A1 prevents maturation of autophagic vacuoles by inhibiting fusion between autophagosomes and lysosomes in rat hepatoma cell line, H-4-II-E cells","volume":"23","author":"Yamamoto","year":"1998","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.taap.2018.08.001_bb0250","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1042\/bse0550105","article-title":"Autophagy and cell death","volume":"55","author":"Yonekawa","year":"2013","journal-title":"Essays Biochem."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18303582?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X18303582?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:46:50Z","timestamp":1758574010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X18303582"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":50,"alternative-id":["S0041008X18303582"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2018.08.001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PIKfyve inhibitor cytotoxicity requires AKT suppression and excessive cytoplasmic vacuolation","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2018.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}